Revolutionizing Therapeutics: Advancements in RNA Medicines|Joseph E. Payne, CEO, Arcturus Therapeutics Holdings Inc. 00:10:00
The interview provides insights into the advancements and potential of RNA medicines, highlighting Arcturus Therapeutics' innovative technologies and collaborations in vaccine development, including their work on COVID-19 vaccines. Joseph, the President and CEO, discusses the company's unique platforms, progress in various disease areas, and future prospects, emphasizing the broader impact of messenger RNA beyond COVID-19 vaccines.
